PASSAGE BIO INC. - COMMON STOCK
0.6294
01-November-24 14:58:16
15 minutes delayed
Stocks
+0.0144
+2.34%
Today's range
0.6100 - 0.6500
ISIN
N/A
Source
NASDAQ
-
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
30 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20 Oct 2023 15:30:00 By Nasdaq GlobeNewswire
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
25 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
07 Aug 2023 06:15:54 By Nasdaq GlobeNewswire
-
07 Aug 2023 06:00:12 By Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming Investor Conferences
01 Aug 2023 06:00:49 By Nasdaq GlobeNewswire
-
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
31 Jul 2023 06:00:59 By Nasdaq GlobeNewswire
-
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
05 Jun 2023 06:00:09 By Nasdaq GlobeNewswire
-
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
11 May 2023 06:00:50 By Nasdaq GlobeNewswire
-
Passage Bio Announces Recipient of Second Annual Tachi Yamada Scholarship Award
04 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 Apr 2023 15:01:17 By Nasdaq GlobeNewswire
-
17 Apr 2023 06:00:35 By Nasdaq GlobeNewswire
-
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
27 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
06 Mar 2023 06:00:41 By Nasdaq GlobeNewswire
-
01 Mar 2023 06:00:02 By Nasdaq GlobeNewswire
-
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
28 Feb 2023 06:00:37 By Nasdaq GlobeNewswire
-
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
27 Feb 2023 06:00:37 By Nasdaq GlobeNewswire
-
24 Feb 2023 06:00:52 By Nasdaq GlobeNewswire
-
15 Feb 2023 06:00:18 By Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 Jan 2023 15:01:55 By Nasdaq GlobeNewswire